Stay updated on ImmunoSarc: Sarcoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The change on the webpage possibly concerns Medical and healthcare-related publications and documentation. The value 'Participation Criteria Collaborators - No information provided' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change represents a shift in focus towards detailing the specific criteria researchers are seeking in participants for the clinical trial.
    Difference
    44%
    Check dated 2024-05-22T08:05:43.000Z thumbnail image
  4. Check
    4 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated completion date and enrollment numbers for the clinical trial involving Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas.
    Difference
    0.0%
    Check dated 2024-05-21T07:48:32.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value '06 thirteen UPS, SS, ASPS, CCS, AS, EHE, SFT, ES, EMC, OS, Ewing'sS, CS, DDCD 03 06' on the webpage has recently changed to '16 two soft tissue sarcoma and bone sarcoma 15 (Estimated) 16'. This change likely reflects an update related to medical and healthcare-related publications and documentation.
    Difference
    0.5%
    Check dated 2024-05-17T02:32:41.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change represents an update in the estimated completion date and enrollment numbers for the clinical trial involving Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas.
    Difference
    0.0%
    Check dated 2024-05-07T20:23:23.000Z thumbnail image
  8. Check
    18 days ago
    Change Detected
    Summary
    The value 2023 07 17 for the treatment plan has been updated to 2024 05 06, indicating a change in the timeline for the treatment regimen. Additionally, the treatment plan has transitioned to two stages, with specific objectives outlined for each stage, focusing on determining recommended doses and evaluating efficacy in patients with advanced soft tissue and bone sarcomas.
    Difference
    43%
    Check dated 2024-05-06T18:41:38.000Z thumbnail image
  9. Check
    24 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T23:01:14.000Z thumbnail image

Stay in the know with updates to ImmunoSarc: Sarcoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.